Improved delivery of poorly soluble compounds using nanoparticle technology: a review

Drug Delivery and Translational Research
Sandeep Kalepu, Vijaykumar Nekkanti

Abstract

Although a large number of new drug molecules with varied therapeutic potentials have been discovered in the recent decade, yet most of them are still in developmental process. This can be attributed to the limited aqueous solubility which governs the bioavailability of such drug molecules. Hence, there is a requisite for a technology-based product (formulation) in order to overcome such issues without compromising on the therapeutic response. The purpose of this review is to provide an insight to the formulation of drug nanoparticles for enhancing solubility and dissolution velocity with concomitant enhancement in bioavailability. In the recent decade, nanonization has evolved from a concept to reality owing to its versatile applications, especially in the development of drugs having poor solubility. In this review, a relatively simple and scalable approach for the manufacture of drug nanoparticles and latest characterization techniques utilized to evaluate the drug nanoparticles are discussed. The drug nanoparticulate approach described herein provides a general applicability of the platform technology in designing a formulation for drugs associated with poor aqueous solubility.

References

Aug 11, 1999·Pharmaceutical Science & Technology Today·B H Böhm, R H Müller
Dec 14, 2001·AAPS PharmSci·N Chidambaram, D J Burgess
Feb 21, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Elaine Merisko-LiversidgeEugene R Cooper
Oct 19, 2004·International Journal of Pharmaceutics·A R MohammedY Perrie
Sep 1, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Cornelia M Keck, Rainer H Müller
Oct 4, 2006·Langmuir : the ACS Journal of Surfaces and Colloids·Michal E MatteucciRobert O Williams
Oct 24, 2007·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jeremy P K TanKam C Tam
Mar 6, 2008·Pharmaceutical Research·Desmond HengJudy A Raper
Mar 14, 2008·Toxicologic Pathology·Elaine M Merisko-Liversidge, Gary G Liversidge
Oct 28, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fabienne DanhierVéronique Préat
Feb 25, 2009·Pharmaceutical Development and Technology·Vijaykumar NekkantiT Harisudhan
Sep 12, 2009·Journal of Pharmaceutical and Biomedical Analysis·Anne HelleTuulia Hyötyläinen
Aug 3, 2010·International Journal of Pharmaceutics·Ranjita Shegokar, Rainer H Müller
Oct 5, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·P KayaertG Van den Mooter
Nov 16, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Daniel JuenemannJennifer B Dressman
Oct 31, 2012·Drug Delivery and Translational Research·Stephanie J WallaceBen J Boyd
Oct 19, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Nrupa BorkarHuiling Mu
Nov 5, 2013·Drug Development and Industrial Pharmacy·Vijaykumar NekkantiRaviraj Pillai

❮ Previous
Next ❯

Citations

Dec 26, 2016·Toxicological Sciences : an Official Journal of the Society of Toxicology·Liecheng YangLeshuai W Zhang
Jun 17, 2020·Drug Development and Industrial Pharmacy·Zibin GaoYanping Sun
Jun 10, 2020·AAPS PharmSciTech·Gamaleldin I HarisaMounir M Salem-Bekhit
Jun 15, 2017·Drug Delivery and Translational Research·William R LykinsTejal A Desai
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mohammad Saiful IslamSomenath Mitra
Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ilma Nugrahani, Maria Anabella Jessica
Aug 22, 2021·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Betty Annie SamuelAnil K Philip

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.